Immunome, Inc. (IMNM)
20.72
-0.16
(-0.77%)
USD |
NASDAQ |
May 18, 09:53
Immunome Shareholders Equity (Quarterly) : 588.69M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.277B |
| Scholar Rock Holding Corp. | 276.01M |
| Stoke Therapeutics, Inc. | 394.88M |
| Nurix Therapeutics, Inc. | 480.89M |
| Exelixis, Inc. | 1.936B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 619.79M |
| Total Liabilities (Quarterly) | 31.11M |
| Debt to Equity Ratio | 0.0063 |
| Current Ratio | 21.68 |
| Net Debt Paydown Yield | 0.01% |